Intuitive Surgical, Inc. $ISRG Shares Acquired by Sovran Advisors LLC

Sovran Advisors LLC increased its stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 96.3% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor owned 2,921 shares of the medical equipment provider’s stock after purchasing an additional 1,433 shares during the quarter. Sovran Advisors LLC’s holdings in Intuitive Surgical were worth $1,581,000 at the end of the most recent quarter.

Several other large investors also recently bought and sold shares of the stock. Riversedge Advisors LLC boosted its stake in shares of Intuitive Surgical by 1.9% in the 4th quarter. Riversedge Advisors LLC now owns 901 shares of the medical equipment provider’s stock valued at $510,000 after buying an additional 17 shares during the period. Fiduciary Financial Group LLC increased its stake in shares of Intuitive Surgical by 2.1% during the fourth quarter. Fiduciary Financial Group LLC now owns 920 shares of the medical equipment provider’s stock worth $521,000 after buying an additional 19 shares during the period. Prosperity Consulting Group LLC increased its stake in shares of Intuitive Surgical by 0.5% during the third quarter. Prosperity Consulting Group LLC now owns 4,033 shares of the medical equipment provider’s stock worth $1,804,000 after buying an additional 19 shares during the period. Rossmore Private Capital raised its holdings in Intuitive Surgical by 2.0% in the third quarter. Rossmore Private Capital now owns 998 shares of the medical equipment provider’s stock valued at $446,000 after acquiring an additional 20 shares in the last quarter. Finally, Activest Wealth Management raised its holdings in Intuitive Surgical by 21.7% in the third quarter. Activest Wealth Management now owns 112 shares of the medical equipment provider’s stock valued at $50,000 after acquiring an additional 20 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Intuitive Surgical Stock Performance

ISRG stock opened at $452.07 on Monday. The stock has a market cap of $160.54 billion, a P/E ratio of 57.30, a PEG ratio of 3.49 and a beta of 1.68. Intuitive Surgical, Inc. has a twelve month low of $425.00 and a twelve month high of $603.88. The company’s 50 day moving average is $487.43 and its two-hundred day moving average is $514.21.

Intuitive Surgical (NASDAQ:ISRG) last issued its earnings results on Thursday, January 22nd. The medical equipment provider reported $2.53 earnings per share (EPS) for the quarter, beating the consensus estimate of $2.27 by $0.26. Intuitive Surgical had a net margin of 28.38% and a return on equity of 15.06%. The business had revenue of $2.87 billion during the quarter, compared to analysts’ expectations of $2.72 billion. During the same quarter in the prior year, the business posted $2.21 EPS. The company’s revenue for the quarter was up 18.8% on a year-over-year basis. On average, equities research analysts predict that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 2,362 shares of the business’s stock in a transaction dated Wednesday, March 4th. The stock was sold at an average price of $498.68, for a total value of $1,177,882.16. Following the completion of the sale, the senior vice president directly owned 3,554 shares of the company’s stock, valued at approximately $1,772,308.72. The trade was a 39.93% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this link. Also, VP Fredrik Widman sold 133 shares of the company’s stock in a transaction dated Wednesday, February 11th. The shares were sold at an average price of $494.96, for a total value of $65,829.68. Following the completion of the sale, the vice president directly owned 660 shares of the company’s stock, valued at approximately $326,673.60. This trade represents a 16.77% decrease in their ownership of the stock. The SEC filing for this sale provides additional information. Insiders have sold a total of 32,943 shares of company stock valued at $17,279,568 over the last ninety days. Company insiders own 0.60% of the company’s stock.

Analysts Set New Price Targets

ISRG has been the subject of several analyst reports. BTIG Research reiterated a “buy” rating and set a $616.00 price target on shares of Intuitive Surgical in a report on Friday, January 23rd. Citigroup upgraded shares of Intuitive Surgical from a “neutral” rating to a “buy” rating and set a $590.00 price objective on the stock in a report on Wednesday, March 11th. Barclays set a $712.00 price objective on shares of Intuitive Surgical and gave the stock an “overweight” rating in a research report on Monday, January 26th. TD Cowen raised Intuitive Surgical to a “strong-buy” rating in a report on Tuesday, January 27th. Finally, Weiss Ratings restated a “hold (c+)” rating on shares of Intuitive Surgical in a research note on Monday, December 29th. One analyst has rated the stock with a Strong Buy rating, sixteen have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat, the company currently has an average rating of “Moderate Buy” and an average target price of $614.95.

Intuitive Surgical Company Profile

Intuitive Surgical, founded in 1995 and headquartered in Sunnyvale, California, is a medical technology company focused on the design, manufacture and service of robotic-assisted surgical systems. The company is best known for its da Vinci surgical systems, which enable minimally invasive procedures by translating a surgeon’s hand movements into finer, scaled motions of small instruments inside the patient. Intuitive’s business centers on supplying hospitals and surgical centers with systems, instruments and related technologies that aim to improve precision, visualization and control in the operating room.

In addition to its core surgical platforms, Intuitive markets a portfolio of reusable and disposable instruments, accessories, and proprietary software, and provides training, servicing and clinical support to its customers.